Back
CYV
Description
Description
Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development and research of novel therapeutic products based on targeting Vascular Endothelial Growth Factors. The company is headquartered in Melbourne, Victoria. The company is engaged in developing novel therapies to treat vision-threatening eye diseases, like wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). Its lead product candidate in Phase 3 development, sozinibercept, is a first-in-class VEGF-C/D trap inhibitor being evaluate...
Show more
ASX
Biotechnology
Performance
Performance
$0.01
AUD
▼ -$0.68 (-98.42%)
16th October 2026, 05:42 a.m.
1M
1Y
10Y
GRAPH
TABLE
GRAPH
TABLE
Quick facts
Quick facts
▼ -99.13% Growth
5 years capital growth
N/A
5 year average dividend yield
$500 minimum investment
Due to regulatory requirements
$10.67 median portfolio
Median amount held by the community
Costs
Costs
PURCHASE FEE
$6.50 AUD (or $5.50 with Pearler Prepay)
MANAGEMENT FEE
N/A
ESG
ESG
15.8
Environmental score
47.61
Social score
49.06
Governance score
Pearler community insights
Pearler community insights
General statistics
12 investors hold CYV
N/A average time between investments
N/A average holding per investor
2 days since last community investment
Demographics
Income of investors
Less than 50k
33%
50k - 100k
27%
100k - 150k
20%
More than 200k
20%
150k - 200k
0%
Age of investors
35-90 years old
58%
26-34 years old
42%
18-25 years old
0%
Legal gender of investors
58% male
42% female
Related items
Related items
Pricing data reflects the most recent end-of-day traded price. Live pricing is shown at the time of buy/sell and may differ from what's displayed here. Other data is provided by our data partner, last updated on Sun Oct 18 2026, and may have changed since.
Learn more
Learn more
Are your index funds actually diversified? | Get Rich Slow Club
READ
First-time investors
Long-term investing
Portfolios
Owning hundreds of companies doesn’t necessarily mean you’re well diversified. It depends on what’s inside the fund.
16 October 2026
・
Tash & Ana
・
8 min read
0 likes
・
2325 views
Job Opportunity – Head of Compliance
READ
Featured articles
We are looking for a Head of Compliance to lead Pearler’s compliance function, work hand in hand with our growth and cre...
15 October 2026
・
Nick Nicolaides
・
7 min read
0 likes
・
2839 views
The Aussie FIRE Audiobook | Conclusion
LISTEN
Congratulations! You've made it to the final chapter of our original Aussie FIRE audiobook. In each chapter, we've cover...
Fri, 3rd November 2023
・
8 min
・
0 likes
Episode 0. Welcome to the Aussie FIRE podcast
LISTEN
Welcome to Aussie FIRE, the podcast designed to educate and inspire you towards a better future! This podcast evolved fr...
Fri, 24th November 2023
・
30 min
・
5 likes
US ETFs vs AU ETFs
ASK & ANSWER
Investing strategy
Are there any downsides to choosing US ETFs over AU ones? Some of the US ETFs outperform AU ones, but as an Australian c...
Stephanie Conroy
•
April 3rd, 2024
0 likes
・
1065 views
・
AU vs US shares
ASK & ANSWER
First-time investor
Hi, I’m fairly new to investing and this is a dumb question but what is the difference when investing in the AU shares v...
Molly Pearse
•
January 29th, 2023
6 likes
・
595 views
・
What’s happened to my shares and it’s value if I suddenly die
ASK & ANSWER
Investing strategy
Hi, I just started my investment with ASX last month. But I started worrying and wanted to know what’s happened to my sh...
Ngoc Nguyen
•
September 30th, 2022
3 likes
・
692 views
・
How to invest your first $500 in Australia (safely) w/ Owen Rask
EVENT
This event ended on Fri, 10th April 2026
Online webinar
・
3 likes
・
Free
3+ people attended
FREE Pearler Webinar | Product Updates & News, October 2024
EVENT
This event ended on Wed, 9th October 2024
Online webinar
・
5 likes
・
Free
130+ people attended